| Website | trellisbio.com |
| Category | BioTech |
| Phone | 650-616-1100 |
| Employees | |
| Description | technology platform |
| Promedior | 5/06 |
| TOTAL | $10M |
| FUNDING TOTAL | $10M |
| Series B, 2/07 Novartis Bioventures Pac-Link Easton Capital Morgenthaler Ventures | $10M |
Trellis Bioscience develops a technology platform for cellular informatics. The company’s technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.
